Annick Moens - Publications

HER2, HER3, and Mismatch Repair Protein Expression in Stage IV Small Bowel Adenocarcinoma: Results From a Multicenter Series.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: April 04, 2025

IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasia.

Journal: Histopathology

Published: August 21, 2023

Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study].

Journal: Journal of Crohn's & colitis

Published: July 15, 2023

Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 10, 2023

Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series.

Journal: Journal of Crohn's & colitis

Published: October 12, 2022

Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center.

Journal: European journal of gastroenterology & hepatology

Published: September 05, 2022

Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study].

Journal: Journal of Crohn's & colitis

Published: April 05, 2022

Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral centre.

Journal: Alimentary pharmacology & therapeutics

Published: November 11, 2021

Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.

Journal: Inflammatory bowel diseases

Published: July 27, 2021

Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

Journal: United European gastroenterology journal

Published: July 08, 2020

Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.

Journal: Inflammatory bowel diseases

Published: October 25, 2019

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.

Journal: Alimentary pharmacology & therapeutics

Published: May 16, 2019